The role of dermatologists in the care of patients with graft-vs-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation varies greatly. In the acute inpatient setting, we are typically called on to perform a “diagnostic” skin biopsy of a nonspecific exanthem, but systemic management may be deferred to the primary transplant team. In the chronic setting, the skin features of GVHD are highly polymorphic and include papulosquamous eruptions, alopecia, dyspigmentation, pruritus, edema, sclerosis, fasciitis, bullae, or ulceration. Given these protean skin manifestations, ideally dermatologists should play an active role in the diagnosis and management of chronic GVHD as part of a multidisciplinary care team.
Cowen EW. Decoding Skin Involvement in Chronic Graft-vs-Host Disease. JAMA Dermatol. 2019;155(7):777–778. doi:10.1001/jamadermatol.2019.0354
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: